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Abstract
Background: The prevalence and incidence of dementia are low in Nigeria, but high among African-Americans. In
these populations there is a high frequency of the risk-conferring APOE-e4 allele, but the risk ratio is less than in
Europeans. In an admixed population of older Cubans we explored the effects of ethnic identity and genetic
admixture on APOE genotype, its association with dementia, and dementia prevalence.
Methods: A cross-sectional catchment area survey of 2928 residents aged 65 and over, with a nested case-control
study of individual admixture. Dementia diagnosis was established using 10/66 Dementia and DSM-IV criteria. APOE
genotype was determined in 2520 participants, and genetic admixture in 235 dementia cases and 349 controls.
Results: Mean African admixture proportions were 5.8% for ‘white’, 28.6% for ‘mixed’ and 49.6% for ‘black’ ethnic
identities. All three groups were substantially admixed with considerable overlap. African admixture was linearly
related to number of APOE-e4 alleles. One or more APOE-e4 alleles was associated with dementia in ‘white’ and
‘black’ but not ‘mixed’ groups but neither this, nor the interaction between APOE-e4 and African admixture (PR
0.52, 95% CI 0.13-2.08) were statistically significant. Neither ethnic identity nor African admixture was associated
with dementia prevalence when assessed separately. However, considering their joint effects African versus
European admixture was independently associated with a higher prevalence, and ‘mixed’ or ‘black’ identity with a
lower prevalence of dementia.
Conclusions: APOE genotype is strongly associated with ancestry. Larger studies are needed to confirm whether
the concentration of the high-risk allele in those with African ancestry is offset by an attenuation of its effect.
Counter to our hypothesis, African admixture may be associated with higher risk of dementia. Although strongly
correlated, effects of admixture and ethnic identity should be distinguished when assessing genetic and
environmental contributions to disease risk in mixed ancestry populations.
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In the only detailed population-based studies from sub-
Saharan Africa, the prevalence and incidence of Alzhei-
mer’s Disease (AD) and dementia in Nigeria are very low
[1,2]. However, among African-Americans, prevalence
and incidence rates are similar to [1,2], or even higher
[3,4] than the rates for white non-Hispanic Americans.
Also, the prevalence of dementia in some Caribbean and
South American populations with African admixture, are
among the highest in the world [5-8].
The e4 allele of the apolipoprotein-E gene was first
reported to be associated with an increased risk of AD
twenty years ago [9,10]. Since then, this has been the
most consistently replicated genetic risk factor [11]. The
association has been observed in many different popula-
tions [12]. However, in African-Americans, other popu-
lations of west African ancestry, and Hispanics the
association of AD with e4 is relatively weak and incon-
sistent, even though the frequency of the risk-conferring
APOE e4 allele is higher in those of African ancestry
than in other continental groups [13]. No association of
APOE genotype with AD has been observed in studies
in Nigeria [14], or Kenya [15]. Two longitudinal studies
in the US also suggest no association between APOE e4
and incident AD among African Americans, while the
incidence of AD seemed to be higher for African Ameri-
cans in every APOE genotype [3,4]. In a case-control
study in Florida the association between APOE e4 and
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observed association among Hispanics in North Man-
hattan [4]. This pattern of findings is strongly suggestive
of the presence of gene by environment, and/or gene by
gene interactions [17].
Those classified in the US as ‘Hispanic’ originate from
diverse mixed ancestry Caribbean, Central and South
American populations, resulting from two-way admix-
ture between Native American and European popula-
tions or three-way admixture among Native American,
European, and West African populations [18]. However,
patterns of admixture vary greatly among these popula-
tions. The catch-all ‘Hispanic’ category is therefore pro-
blematic, providing some information about linguistic
and cultural heritage but very little about ancestry. In
much of continental Latin America, two-way admixture
dominates with little evidence of African ancestry [19].
Cuba is quite different. The first European contact was
by Columbus in 1492. The indigenous population was
reputedly extinct by 1700. While the ancestral Native
American substrate is still appreciable in the maternal
lineages, the extensive process of population admixture
in Cuba has left no trace of paternal Native American
lineages, mirroring the strong sexual bias in the admix-
ture processes taking place during colonial times [20];
currently Native American admixture is minimal [21].
Importation of slaves from West Africa was current by
1600 and not abolished until 1886. The proportion of
population identified as black or mixed rose from 34%
in 1774 to 57% by 1817. Recent Cuban studies concur
in identifying average proportions of African admixture
in those who classify themselves as white, mixed race
and black as, respectively, about 5%, 35% and 60%
[20,21]. European admixture among African-Americans
is much lower, an average of between 12% and 20% in
different US cities [22] and very few African-Americans
have as much as 50% European ancestry [23]. In the for-
mer British Caribbean, average European admixture
levels may be even lower; just 7% in Jamaica [22].
The high levels of African and European admixture in
Cuba can be used to good effect. Studying the relation-
ship of dementia risk to individual admixture within
admixed populations is the most direct way to distin-
guish genetic from environmental explanations for eth-
nic differences in disease risk [24], and, by extension, for
distinguishing gene by environment versus gene by gene
explanations for ethnic differences in the effects of
genes on disease outcomes. Furthermore, such relation-
ships will confound studies of other genetic risk factors
- “hidden population stratification”. Measurement of the
confounder (individual admixture) allows us to control
for population stratification using standard methods.
We recently reported a high prevalence of dementia in
a one phase prevalence study in an older Cuban urban
population [25]. In the present study we aimed to
1. analyse the association between ethnic group and
individual admixture
2. assess the association of each with APOE genotype
3. test the hypotheses that
a. the effect of APOE genotype on dementia is modi-
fied by ethnic group, and/or admixture, with weaker
associations among those with ‘mixed’ and ‘black’
ethnic identity and with higher proportions of Afri-
can admixture
b. the prevalence of dementia is lower among those
with ‘mixed’ and ‘black’ ethnic identity, and is inver-
sely linearly related to African admixture
Methods
Setting and Study design
A one phase cross-sectional catchment area survey of all
those aged 65 years and over living in five catchment
areas in Ciudad Havana, Cuba (Lisa, Luyano, Marianao,
Playa, and Plaza); and one catchment area in Matanzas
(Milanes), a city 120 kilometres east from Havana, and a
nested case-control comparison of admixture. This
involved estimating individual admixture on all demen-
tia cases and a randomly selected sample of controls
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reduces the cost of the genotyping work while retaining
much of the power for the tests of the main hypotheses.
All participants received a full assessment lasting
approximately 2-3 hours, including a participant inter-
view, a physical examination, phlebotomy, and an infor-
mant interview. Interviews were carried out by
polyclinic doctors (psychiatrists, geriatricians or general
medical specialists) working in the areas selected. Parti-
cipants were recruited on the basis of informed signed
consent. The Medical University of Havana, the
National Centre of Medical Genetics (Cuba), and the
Institute of Psychiatry institutional review boards
reviewed and approved this project. Full details of the
protocol for the 10/66 population-based cross-sectional
surveys are provided in an open-access online journal
publication [26].
Measures
The 10/66 interview generates information on dementia
diagnosis, mental disorders, physical health, anthropo-
metry, demographics, dementia and non-communicable
disease risk factors, disability and functioning, health
service utilisation, care arrangements and caregiver
strain [26]. Only those assessments relevant to the cur-
rent analysis of dementia, ethnicity, admixture and
APOE genotype are described in detail here.
1) Outcome - The diagnosis of dementia.
Dementia was diagnosed according to our own cross-
culturally validated 10/66 dementia diagnosis algorithm
[27], and according to DSM-IV criteria [28]. A concur-
rent validation conducted in the course of the Cuban
population-based study showed that DSM-IV dementia
diagnosis was specific but insensitive to mild to moder-
ate dementia; the 10/66 Dementia diagnosis corre-
sponded better to local clinician diagnosis and was more
sensitive to these milder cases [29]. The outcome for
most of the analyses in this paper is ‘any dementia diag-
nosis’ comprising all those meeting either or both of
these criteria. Diagnoses were established following.
(i) A structured clinical interview, the Geriatric Mental
State, which applies a computer algorithm (AGECAT)
[30], identifying organicity (probable dementia), depres-
sion, anxiety and psychosis and,
(ii) A cognitive test battery comprising a) the Commu-
nity Screening Instrument for Dementia (CSI’D’)C O G -
SCORE [31] (incorporating the CERAD animal naming
verbal fluency task), and b) the modified CERAD 10
word list learning task with delayed recall [32] and
(iii) An informant interview, the CSI’D’ RELSCORE
[31] for evidence of cognitive and functional decline,
with additional information on dementia onset and
course obtained from the modified (Dementia Diagnosis
and Subtype) History and Aetiology Schedule [33].
Participants were allocated to the category of 10/66
dementia when they scored above a cutpoint of pre-
dicted probability of dementia (>0.25) estimated from
the logistic regression equation developed and validated
cross-culturally in the 10/66 international pilot study,
using coefficients from the GMS, CSI-D informant and
cognitive test interviews and the modified CERAD 10
word list learning tasks [27]. DSM-IV dementia is a cri-
terion-based diagnosis requiring impairment in memory
and at least one other domain of cognitive function,
linked to social or occupational impairment, not better
accounted for by delirium or other mental disorder.
DSM-IV dementia criteria were applied directly using a
computerized algorithm; full details are available in an
open access publication [29].
2. Ethnic identity: Participants were classified accord-
ing to interviewer’s perception of ethnic identity, using
well-established groups used in the Cuban census -
‘Blanco - white’, ‘Mestizo - mixed’ and ‘Negro - black’.
3. APOE Genotyping: We aimed to collect 10 ml
blood samples from all participants, from which DNA
was extracted, quantitated, and archived at the National
Centre for Medical Genetics in Havana. Apolipoprotein
E genotype was determined using Hhal digestion of
amplified products. Genotypes were determined masked
to knowledge of clinical phenotypes.
4 .A d m i x t u r ee s t i m a t i o n :I nap o p u l a t i o nf o r m e db y
admixture between two or more founding populations,
ancestry informative marker genotype data can be used
to estimate the admixture of each individual (the propor-
tion of that individual’s genome that has ancestry from
each founding population). We aimed to estimate admix-
ture in 600 participants, comprising all dementia cases,
and a randomly selected sample of controls. Sixty SNPs
were used to estimate individual admixture, chosen from
the panel assembled by Dr Mark Shriver at Penn State
and Mike Smith at NCI [34]. With an average 40% infor-
mation content for ancestry, these 60 SNPs would be suf-
ficient to estimate three-way individual admixture
proportions with a standard error of less than 0.1 (see
additional file 1 for details of individual SNPs and their
locations). All genotyping was performed by KBios-
ciences (Mapple Park, Herts, UK; http://kbioscience.co.
uk). SNPs were genotyped using the KASPar chemistry,
which is a competitive allele specific PCR SNP genotyp-
ing system using FRET quencher cassette oligos (http://
www.kbioscience.co.uk/reagents/KASP.html). Plate-iden-
tifying blanks and Hardy-Weinberg equilibrium tests
were used as quality control tests. The ADMIXMAP pro-
gram [35] (http://homepages.ed.ac.uk/pmckeigu/admix-
map/) was used to generate posterior means of individual
admixture from the ancestry informative marker data. In
large samples these posterior means are asymptotically
equivalent to maximum likelihood estimates.
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We describe sample characteristics, comparing those in
full survey sample who did and did not provide a blood
sample, and for the case-control sub-sample the sam-
pling weights (the inverse of the probability of selection)
for dementia cases and controls within each APOE gen-
otype. We describe the proportions assigned to each
ethnic identity (’white’, ‘mixed’ and ‘black’), and the
weighted mean individual admixture proportions (Eur-
opean, African and Native American), and, in the sub-
sample, test for an association between them using a
weighted one way ANOVA.
We next tested for an association between ethnic
identity and APOE genotype and allele frequencies
using a Chi-squared test for trend, and an association
between APOE genotype and admixture by making a
weighted comparison of mean admixture across groups
with no, one or two APOE e4 alleles.
We tested for an association between APOE genotype
and any dementia with Chi-squared tests and crude and
adjusted prevalence ratios derived from a Poisson work-
ing model (adjusted for age, sex and educational level).
To control for population stratification, the adjusted
prevalence ratio for any APOE e4 allele was further
adjusted for ethnic identity, and, in the weighted Pois-
son model in the case-control sub-sample, for admix-
ture. We next estimated the stratum-specific prevalence
ratios for the association between any APOE e4 allele
and any dementia in the three ethnic identity groups,
and fitted a ethnic identity by APOE interaction term to
t h em o d e l .W ea l s of i t t e da nA f r i c a na d m i x t u r eb y
APOE interaction term to the weighted Poisson model
in the case-control sub-sample.
Finally, we assessed the separate and joint effects of
ethnic identity and admixture on dementia prevalence.
In the full sample, we describe the crude prevalence of
dementia by ethnic identity, and the prevalence of
dementia standardised for age, sex and education, and
age, sex, education and APOE genotype. Alongside the
crude and adjusted prevalence, we also provide preva-
lence ratios from the analogous Poisson model. In the
case-control sub-sample in aw e i g h t e da n a l y s i sw ee s t i -
mated the main effect of admixture (100% African ver-
sus 100% European) on dementia controlling for age,
sex, education and APOE genotype. We accomplished
this by entering both African and North American pro-
portionate admixture into the models, as continuous
scales ranging from 0.0 to 1.0, but omitting European
admixture. Since proportions for these three variables
sum to 1.0 for each participant, European admixture
becomes in effect the contrast (akin to the omitted cate-
gory when using dummy variables), and the coefficient
for African admixture is then interpreted as the change
in the log prevalence ratio per one unit change in
African admixture, that is between 100% African and
100% European admixture. However, the underlying
assumption is one of linear variation across this range.
Then, in a series of models, we estimated the separate
and joint effects of ethnic identity and admixture con-
trolling only for APOE genotype, and then the joint
effects controlling also for age, sex and education.
All analysis were carried out using STATA version
9.2.
Results
Sample characteristics
Of the 2928 participants completing the survey (an
overall response rate of 96.4% of all those eligible), 2520
(86.1%) provided blood samples for APOE genotyping
and biomarker analysis. Men (p = 0.07) were slightly
under-represented among those not providing blood
samples (Table 1). Otherwise, there were no large or
statistically significant differences between the two
groups regarding education, prevalence of dementia,
family history of dementia and prevalence of self-
reported stroke, diabetes, hypertension and smoking. Of
the 273 people with dementia that provided blood sam-
ples 235 were found to be suitable for SNP genotyping,
and 349 control samples were selected at random from
all non-cases. Of these 235 people with dementia, 231
met criteria for 10/66 dementia, 137 met DSM-IV
dementia, and 133 met both criteria. To ensure that
estimates would be generalisable, for all subsequent
case-control analyses, sample weights were used to
weight back for the probability of selection within case
and control groups by APOE genotype. For the cases
these were APOE e2/e3 1.00; e2/e4 1.00; e3/e3 1.11; e3/
e4 1.68; e4/e4 1.14. For the controls these were APOE
e2/e3 5.10; e2/e4 3.50; e3/e3 8.16; e3/e4 4.54; e4/e4
2.15. This sampling variation was based on observed fre-
quencies rather than design, and must, presumably, have
arisen through chance.
The association between ethnic identity and admixture
According to interviewer perceptions, 1677 (72%) were
considered to be ‘white’, while 394 (17%) were consid-
ered ‘mixed’ and 261 (11%) ‘black’. For the case-control
sub-sample (n = 584), the mean individual admixture
proportions (after weighting back) were European 81.2%
(95% confidence intervals 79.1-83.3%), African 16.2%
(14.1-18.3%), and Native American 2.6% (2.3-3.0%). The
mean African admixture proportion for the three ethnic
groups was 5.8% (5.1-6.6%) for ‘white’, 28.6% (24.0-
33.2%) for ‘mixed’ and 49.6% (44.8-55.4%) for ‘black’.
However, all three groups were substantially admixed
with considerable overlap between the three ethnic iden-
tities, pure African or European ancestry being the
exception (see Figure 1). A small proportion of those
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of those defined as ‘black’ had inherited much of their
genome from European ancestors.
The association between ethnic identity, admixture and
APOE genotype
Table 2 shows the distribution of APOE genotype and
APOE allele frequency according to ethnic identity.
There was a strong graded association between ethnic
identity and APOE genotype, with lower e3 frequency
and higher e2 and e4 frequencies moving from ‘white’
to ‘mixed’ to ‘black’ groups. In the case-control sub-
sample, there were also graded associations (after
weighting back) between individual admixture and
APOE genotype. Mean African admixture increased
from 0.15 among those with no e4 alleles to 0.19 with
one and 0.35 for those with two e4 alleles (Test for
trend, F = 4.6, p = 0.01), while mean European admix-
ture declined across the three groups from 0.82 to 0.78
to 0.62 (Test for trend, F = 5.0, p = 0.007). Native
American admixture (0.03) did not vary by APOE
genotype.
The association between APOE genotype and dementia;
interactions with ethnic group and admixture
The distribution of APOE genotype and the APOE allele
frequency, by dementia status, is shown in table 3. The
e2 allele was under-represented, and the e4 allele over-
represented among those with dementia. We examined
the effect of APOE genotype on dementia prevalence
using APOE e3/e3 genotypes as the reference category.
After adjusting for age, sex and education, APOE e3/e4
(PR = 2.59, 95%CI 2.04-3.28) and APOE e4/e4 geno-
types (PR 2.88, 95% CI1.58-5.27) were strongly asso-
ciated with dementia. However, there was no apparent
protective effect of the e2 allele. The prevalence of
dementia was more than double in APOE carriers com-
pared to that in non-carriers (adjusted PR = 2.58, 95%CI
2.06-3.22). This adjusted prevalence ratio was little
changed after adjusting also for ethnic identity (PR 2.47,
95% CI 1.96 to 3.12). After weighting back, the associa-
tion between any APOE e4 allele and dementia, adjusted
for age, sex and educational level was naturally similar
in the case-control sub-sample, although estimated with
less precision (PR 2.54, 95% CI 1.85-3.47). This associa-
tion was also essentially unchanged after further adjust-
ing for individual admixture (PR 2.57, 95% CI 1.89-3.49).
Stratifying by ethnic identity in the full sample, the
association between any APOE-e4 and dementia was
similar in ‘white’ (PR 2.83, 95% CI 2.18-3.68) and ‘black’
participants (PR 2.38, 95% CI 1.43-3.95), with no asso-
ciation apparent among those rated as having ‘mixed’
race (PR 0.87, 95% CI 0.25-2.98). However, the likeli-
hood ratio test for the interaction term was not statisti-
cally significant (X
2 =4 . 4 2 ,d e g r e e so ff r e e d o m=2 ,p=
0.11). In a sensitivity analysis, after merging the ‘mixed’
and ‘black’ groups, the interaction between APOE e4
and ethnic identity showed a non-significant trend
Table 1 Sample characteristics, by availability of blood sample
Variables Without blood sample
N = 408
With blood sample
N = 2520
P-value (T-test with F-value,
or chi-squared test)
Age in years (mean/sd) Missing values 75.4 (7.2) 0 75.0 (7.0) 7 F = 2.4, p = 0.27
Male sex (n/%) 159 (39.0%) 866 (34.4%) X
2 = 3.3, 1 df, p = 0.07
Ethnic identity X
2 = 1.9, 2 df, p = 0.39
’White’ 77 (69.4%) 1674 (71.9%)
’Mixed’ 17 (15.3%) 260 (11.2%)
’Black’ 17 (15.3%) 395 (17.0%)
Missing values 97 191
Dementia (n/%) 47 (11.5%) 273 (10.8%) X
2 = 0.2, 1 df, p = 0.68
ICD depressive episode (n/%) 19 (4.7%) 125 (5.0%) X
2 = 0.1, 1 df, p = 0.79
Stroke (n/%) 35 (8.6%) 194 (7.7%) X
2 = 0.4, 1 df, p = 0.53
Missing values 2 7
Diabetes (n/%) 71 (17.5%) 471 (18.8%) X
2 = 0.4, 1 df, p = 0.53
Missing values 2 14
Hypertension (n/%) 295 (72.3%) 1841 (73.1%) X
2 = 0.1, 1 df, p = 0.75
Smoking (n/%) 176 (43.2%) 1141 (45.4%) X
2 = 0.7, 1 df, p = 0.41
Missing values 1 8
Family history of dementia (n/%) 75 (18.5%) 473 (18.8%) X
2 = 0.0, 1 df, p = 0.86
Missing values 2 8
Df = degrees of freedom.
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non-whites compared with whites (PR 0.74, 95% CI 0.45-
1.24). In the case-control subsample, extending the
model to include an APOE by African ancestry interac-
tion term suggested that the effect (prevalence ratio) of
any APOE e4 allele would vary continuously from PR
2.93 (95% CI 1.99-4.31) in those with 100% European
ancestry to 1.52 in those with pure African ancestry.
However, the interaction term again failed to reach statis-
tical significance (PR 0.52, 95% CI 0.13-2.08), p = 0.36.
Effects of ethnic identity and admixture on dementia
prevalence
There were no statistically significant effects of ethnic
identity on dementia prevalence, either before or after
adjusting for compositional differences (Table 4). The
prevalence of dementia was slightly higher among
‘black’ participants and slightly lower among ‘mixed’
participants when compared with ‘white participants,
these tendencies being amplified after standardizing
or adjusting for age, sex and education (Table 4).
After further standardizing or adjusting for the com-
positional differences in APOE genotype, dementia
prevalence among both ‘black’ and ‘mixed’ groups was
slightly lower than among those identified as ‘white’.
In the case-control subsample the prevalence ratio for
100% African versus 100% European ancestry was PR
0.81 (95% CI 0.41-0.63). After fitting the APOE x
African admixture interaction term, the effect of Afri-
can ancestry was estimated as PR 1.01 (95% CI 0.43-
2.39) in those without an APOE e4 allele and 0.52 in
those with an APOE e4 allele - albeit that as noted
before the interaction term was not statistically
significant.
When estimating simultaneously the independent
effects of ethnic identity and admixture (controlling for
APOE genotype) African admixture was positively asso-
ciated with dementia prevalence (PR 4.62, 95% CI 1.48-
14.5), while estimated prevalence in ‘mixed’ (PR 0.54,
95% CI 0.30-0.96) and ‘black’ participants (PR 0.50, 95%
CI 0.25-1.00) was significantly lower than among those
identified as ‘white’ (Table 5). The effect of African
admixture was slightly attenuated after adjusting for age,
sex and education.
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Figure 1 Box plot of African admixture distribution by ethnic
identity (weighted).
Table 2 Distribution of sociodemographic characteristics, APOE genotype and APOE allele frequency by ethnic identity
Ethnic identity ’White’
N = 1674
’Mixed’
N = 260
’Black’
N = 395
P value X
2
Age (mean/SD) 75.0 (7.0) 75.7 (7.7) 74.7 (6.9) F = 1.7, P = 0.19
Male sex (n/%) 579 (34.6%) 95 (36.5%) 118 (29.9%) X
2 = 4.0, 2df, P = 0.14
Education level (n/%) X
2 = 25.6, 1 df, P < 0.001
None 37 (2.2%) 7 (2.7%) 14 (3.6%)
Some 344 (20.6%) 55 (21.2%) 112 (28.5%)
Primary 543 (32.5%) 87 (33.5%) 148 (37.7%)
Secondary 429 (25.7%) 62 (23.8%) 73 (18.6%)
Tertiary 317 (19.0%) 49 (18.8%) 46 (11.7%)
APOE Genotype (n/%) X
2 = 31.4, 1 df, P < 0.001
No E4 allele 1423 (85.0%) 222 (85.4%) 298 (75.4%)
Heterozygous (One e4 allele) 241 (14.4%) 32 (12.3%) 77 (19.5%)
Homozygous (Two e4 alleles) 10 (0.6%) 6 (2.3%) 20 (5.1%)
APOE allele frequency X
2 = 42.6, 4 df, P = < 0.001
E2 0.058 0.063 0.072
E3 0.864 0.852 0.780
E4 0.078 0.085 0.148
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There has been much interest in the potential role of
African ancestry in modifying the effect of the APOE
genotype and influencing risk for AD and other demen-
tias. We believe this to be the first study to have
addressed this issue directly, through estimation of indi-
vidual admixture, rather than relying merely on observa-
tions of ethnic type. Another strength is the population-
based survey design with high response rates for the
main survey and blood sample collection. The main
weaknesses of the study were, first, that the sample size,
although large, may not have been adequate to exclude
important APOE genotype by admixture interaction
effects, and second that in the cross-sectional design we
were unable to distinguish environmental factors asso-
ciated with the incidence of dementia from those pre-
dicting its duration. Finally, although the use of 60 SNPs
to estimate individual admixture is considered to pro-
vide reasonable precision, a standard error of around 0.1
is to be expected. Ideally we should have accounted for
the uncertainty in these estimates within the regression
analysis, rather than treating it as a covariate observed
without error. We do not believe that this will have led
to systematic error, since most SNPs were successfully
genotyped on most participants. Nevertheless, although
much more computationally demanding, future more
definitive tests of these hypotheses on larger samples
would benefit from this more rigorous approach
In this representative population-based survey of older
Cubans in Havana and Matanzas cities, ‘’white’,m i x e d ’
and ‘black’ ethnic groups were all substantially admixed,
with varying proportions of African and European
ancestry. There was a strong and statistically significant
association between both ethnic identity and admixture
and the APOE genotype, the e4 allele being over-repre-
sented in ‘mixed’ and ‘black’ ethnic groups and in those
with greater African admixture. Overall, we found a
strong association between APOE genotype and demen-
tia, with effect sizes very similar to those reported in
other settings [11,13]. The association was evident
among those identified by interviewers as ‘black’ as well
as those identified as ‘white’, but not in those identified
Table 3 APOE Genotype and APOE allele frequency by dementia status, with crude and adjusted prevalence ratios and
95% confidence intervals
Dementia
N(%) 273
No
dementia
N(%) 2247
Whole sample
N(%) 2520
Crude PR
(95%CI)
Adjusted
1 PR
(95%CI)
APOE genotype e2/e3 24
(8.8%)
255
(11.4%)
279
(11.1%)
0.97 (0.64-1.46) 0.96 (0.64-1.44)
e2/e4 2
(0.7%)
15
(0.7%)
17
(0.7%)
1.33 (0.36-4.91) 1.42 (0.37-5.45)
e3/e3 162
(59.3%)
1663
(74.0%)
1825
(72.4%)
1.00 (ref.) 1.00 (ref.)
e3/e4 77
(28.2%)
285
(12.7%)
362
(14.4%)
2.40 (1.88-3.06) 2.59 (2.04-3.28)
e4/e4 8
(2.9%)
29
(1.3%)
37
(1.5%)
2.44 (1.30-4.57) 2.88 (1.58-5.27)
p-value (Test for
heterogeneity)
X
2 = 54.6, 4 df
p < 0.001
X
2 = 46.6, 4 df
p < 0.001
Number of APOE e4
alleles
0 186
(68.1%)
1918
(85.4%)
2104
(83.5%)
1.00 (ref.) 1.00 (ref.)
17 9
(28.9%)
300
(13.4%)
379
(15.0%)
2.36 (1.86-2.99) 2.55 (2.02-3.21)
28
(2.9%)
29
(1.3%)
37
(1.5%)
2.45 (1.31-4.58) 2.90 (1.59-5.29)
p-value (Test for trend) X
2 = 55.5, 1 df
p < 0.001
X
2 = 41.8, 1 df
p < 0.001
Any APOE e4 allele 1 or 2 alleles 87
(31.9%)
329
(14.6%)
416
(16.5%)
2.37 (1.88-2.98) 2.58 (2.06-3.22)
p-value X
2 = 53.0, 1 df
p < 0.001
X
2 = 45.6, 1 df
p < 0.001
APOE allele frequency e2 0.048 0.060 0.059
e3 0.778 0.860 0.851
e4 0.174 0.080 0.090
p-value (Test for trend) X
2 = 61.7, 1 df,
P < 0.001
1 Adjusted for age, sex and education - X
2 derived from likelihood ratio tests.
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Page 7 of 11as ‘mixed’.T h e‘mixed’ group was the smallest in num-
ber, and lack of precision may have contributed to this
otherwise surprising finding. There was a non-significant
trend for the association between APOE genotype and
dementia to be weaker in those with greater degrees of
African admixture. Controlling for ethnic identity or
admixture did not affect the association between APOE
genotype and dementia, suggesting an absence of con-
founding by population stratification. After controlling
for compositional differences in APOE genotype (the
Table 4 Crude and adjusted dementia prevalence by ethnic identity, with prevalence ratios
’White’
N = 1677
’Mixed’
N = 394
’Black’
N = 261
Test for
heterogeneity across
ethnic identity
groups
Crude prevalence
Any dementia - crude
prevalence (%)
190/1751
10.9%
(9.4-12.3%)
25/277
9.0%
(5.5-12.5%)
49/412
11.9%
(8.8-15.0%)
Crude prevalence ratio 1 (ref) 0.83
(0.55-1.25)
1.10
(0.82-1.47)
X
2 = 1.0, 2 df p = 0.61
Standardized/adjusted for age, sex and
education
1
Any dementia - standardized
prevalence (%)
11.1%
(9.7-12.5%)
7.8%
(5.0-10.6%)
11.8%
(8.6-15.1%)
Adjusted prevalence ratio 1 (ref) 0.73
(0.50-1.06)
1.04
(0.79-1.38)
X
2 = 2.5, 2 df p < 0.29
Standardized/adjusted for age, sex, education
and APOE genotype
1
Any dementia - standardized
prevalence (%)
11.4%
(10.0-12.8%)
8.3%
(5.4-11.2%)
9.7%
(7.3-12.1%)
Adjusted prevalence ratio 1 (ref) 0.74
(0.50-1.10)
0.92
(0.69-1.23)
X
2 = 2.2, 2 df p = 0.32
1. X
2 derived from likelihood ratio tests
Table 5 The independent effects of admixture and ethnic identity upon dementia prevalence (weighted analysis)
Model 1 Model 2 Model 3 Model 4
APOE genotype
One or more e4 allele 2.21 (1.58-3.09)
p < 0.001
1
2.19 (1.54-3.10)
p < 0.001
1
2.13 (1.50-3.02)
p < 0.001
1
2.45 (1.77-3.40)
p < 0.001
1
Admixture
100% African versus 100% European admixture 1.53 (0.80-2.91)
p = 0.20
1
- 4.62 (1.48-14.5)
p = 0.01
1
2.55 (0.75-8.61)
p = 0.13
1
Ethnic identity
’White’ - 1 (ref) 1 (ref) 1 (ref)
’Mixed’ - 0.79 (0.47-1.33)
p = 0.38
1
0.54 (0.30-0.96)
p = 0.04
1
0.60 (0.34-1.09)
p = 0.09
1
’Black’ - 1.02 (0.68-1.51)
p = 0.93
1
0.50 (0.25-1.00)
p = 0.05
1
0.47 (0.22-1.02)
p = 0.06
1
Sociodemographic factors
Age (years) - - - 1.10 (1.07-1.12)
p < 0.001
1
Male sex - - - 0.84 (0.59-1.21)
p = 0.36
Education (per level) - - - 0.76 (0.64-0.90)
p = 0.001
1. p-values are taken from the model z-scores. It was not possible to run likelihood ratio tests because robust variance estimates were required given the use of
sampling weights.
Model 1 African admixture and APOE.
Model 2 Ethnic identity and APOE.
Model 3 African admixture, ethnic identity and APOE.
Model 3 African admixture, ethnic identity, APOE, age, sex and education.
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Page 8 of 11risk conferring e4 allele being more common in ‘mixed’
and ‘black’ ethnic identity groups), there was a non-sig-
nificant trend towards lower dementia prevalence in
those ‘non-white’ groups. A similar non-significant trend
was apparent for admixture. However, when the joint
independent effects of ethnic identity and admixture
were assessed in a single model, mutual confounding
was evident. In each ethnic identity, increased African
ancestry greatly increased the risk of dementia. At every
level of African ancestry, those with ‘mixed’ and ‘black’
ethnic identities had a lower risk of dementia
We have established a link between admixture and
APOE genotype, with a higher frequency of the risk-
conferring e4 allele in those with greater degrees of
African admixture. All things being equal, this would be
expected to result in a greater incidence and prevalence
of dementia. However, in our sample this was offset by
a large attenuation of the effect of APOE e4 in those
with more African ancestry. This interaction was not
statistically significant, and larger samples will be
required to measure this with more precision and
exclude type II error. Also, there was no significant
graded effect modification by ethnic identity in the lar-
ger sample, with the attenuation of effect being confined
to those in the ‘mixed’ group. Gene by environment
interactions still seem the most plausible explanation for
apparent modification of the effect of APOE among
African, African American and European populations,
given the large difference in environmental exposures,
particularly cardiovascular risk factors, between African
and African American populations [36]. However, Eur-
opean admixture among African American populations
may have also created potential for differential gene by
gene interactions between the two settings. Were a
more consistent and unequivocal interaction with
admixture to be demonstrated in larger samples, we
could then in principle begin to localize the genes
responsible by admixture mapping, exploiting informa-
tion about linkage generated by admixture [35].
Another balancing effect on overall prevalence may be
in operation given that the effects of ‘mixed’ or ‘black’
ethnic identity on the one hand, and African genetic
admixture on the other seem to be operating in oppos-
ing directions in influencing dementia risk. These are
related yet by no means collinear constructs; hence
mutual confounding is feasible. The new respectability
of observer assessments of ‘ethno-race’ in epidemiologi-
cal research arise precisely from their ability to identify
the externally observable physical characteristics that are
hypothesised to lead to social, economic and health dis-
advantage. Their utility in research, as well as their lim-
itations are neatly summarised by an American
epidemiologist, Camara Phyllis Jones [37]:
’The race that we measure in our studies is the same
race that is noted by a taxi driver, a police officer, a
judge in a courtroom, or a teacher in a classroom. That
is, race is a social classification in our race-conscious
society that conditions most aspects of our daily-life
experiences and results in profound differences in life
chances. This assigned race varies among countries. For
example in the United States I am clearly labelled Black,
while in Brazil I would be just as clearly labelled White
and in South Africa, I would be clearly labelled
‘coloured’. It is likely, if I stayed long enough in one of
these settings, my health profile would become that of
the group to which I had been assigned, even though I
would have the same genetic endowment in all three
settings.’
Much research in the US has focussed upon black eth-
nic identity as a socially determined, contextually bound
construct, linked to disadvantage and discrimination,
and mediating health disadvantages. Thus, in the 1990s
darker skin colour among African-Americans was found
to be inversely associated with income, education and
occupational status, and to be a stronger predictor of
adult occupational status than was parental socioeco-
nomic position [38]. More recently, darker skin colour
has been shown to be independently associated with
experiences of racism [39]. Protective income gradients
in hypertension are evident for light-skinned but not
dark-skinned African-Americans, an effect hypothesised
to be explained by psychosocial stressors linked to skin
colour, including racism [40]. Of relevance to our find-
ing of a protective effect of non-white ethnic identity on
dementia risk, some benefits of such self-identification
have been reported; for example factors reflecting parti-
cipation in and belonging to African-American culture
were associated with a range of positive health beha-
viours [41].
Conclusions
Genetic admixture, externally observable physical
characteristics including skin colour, and self-reported
ethnicity are related to each other, but in complex
ways [42,43]. One of the weaknesses in the current
s t u d yi st h a tw ed i dn o ta d e q u a t e l ys e p a r a t eo u ts e l f -
perceptions from observer ratings of ethnic identity.
A proper understanding of the role of genetic admix-
ture in determining disease risk may require measure-
ment of, and control for each of these and other
related socio-cultural factors, including socioeco-
nomic position and acculturation [37,44]. Although
strongly correlated, the effects of admixture and eth-
nic identity on health outcomes can and should be
distinguished when assessing genetic and environ-
mental contributions.
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